Chinese Journal of Clinical Pharmacology and Therapeutics 2006 Issue 1 Progress of clinical pharmacological study on rifabutin

Progress of clinical pharmacological study on rifabutin
LI Zhao-xu;ZHANG Jin-nan;REN Shuang;GAO Cheng-ying;SUN Yi;WANG Xue

..............page:1-9

Nitric oxide synthase inhibitors and cerebral ischemia
HU Miao-miao;LI Yun-man

..............page:10-13

Progress in anti-multidrug resistance mediated by p-glycoprotein
MA Bing-liang;WU Yu-lin;LIU Guo-qing

..............page:14-21

Role of cyclooxyenase and its inhibitors in prevention and treatment of cancer
LU Li-na;YANG Ting;ZHUANG Ze-hao

..............page:22-26

Regulation effect of arecoline on excess expression of adhesive molecules in endothelial cells injuried with high concentration of D-glucose
DUAN Zhi-bian;WANG Hai

..............page:27-32

Bcl-XL siRNA sensitizes human MGC-803 gastric cancer cells to 5-fluorouracil and diallyl disulfide
ZHONG Miao;LEI Xiao-yong;FENG Lan-fang;ZHU Bing-yang;TANG Sheng-song;LIAO Duan-fang

..............page:33-38

Effects of tubeimoside on adhension, invasion and migration of a human highly metastatic giant lung carcinoma cell line PGCL3
WANG Chang-xiu;MA Run-di;YU Li-jian

..............page:39-44

Lomerizine inhibited the function of P-glycoprotein(P-gp) without decreasing the expression of mdr1 gene and P-gp in primarily cultured rat brain microvessel endothelial cells
WU Yu-lin;MA Bing-liang;ZHU Hao-jie;LIU Guo-qing

..............page:45-50

Protective effects of Hypericum perforatum on ischemic injury in PC12 cells
DAI Xiao-ming;SUN Rong;WU Dong-dong;WU Yu-lin

..............page:51-54

Role of NF-kappa B in regulating expression of ICAM-1
ZHANG Xue-ping;LIU Xin-bo;REN Yong-gong;SHI Bi-ming;LI Ya-li;YAO Shang-long;ZENG Bang-xiong

..............page:55-58

Extraction of anti-CPG ODN component from Terminaliachebula retz and their activity evaluation
YAO Jie;ZHENG Jiang;JIANG Dong-neng;LU Yong-ling;WEI Li-zhao

..............page:59-61

Urinary excretion of genistein and its metabolite at different doses in rats
ZHOU Si-yuan;TENG Zeng-hui;LIU Xin-you;RAN Yu-hua;YANG Run-tao;XIAO Yi;WANG Si-wang;MEI Qi-bing

..............page:62-65

Study of pharmacokinetics of secnidazole vagina effervescent tablets in healthy volunteers
WANG Shao-hua;ZHAO Yan;LIU Zhen-sheng;LI Zhi-ping;WANG Xia;ZHAO Mei-ling;QI Fang-mei

..............page:66-69

Experimental study on radioprotective and cytoprotective activities of facteur thymic serique in mice
LI Zhan-jun;LIAO Xiao-quan;XU Kang-sen

..............page:70-73

Meta-analysis of effectiveness of fluoxetine in treatment of post-stroke depression
JIANG Ya-bin

..............page:74-77

Investigation of bioequivalence of capsules and tablets of complex chlorzoxazone in healthy volunteers
ZHU Jin-xiu;LI Jian-chun;HU Qi-sheng;DONG Hai-jun;GAO Shu;JIANG Zhi-wen

..............page:78-81

Protection of hepatic stimulator substance against chemotherapeutic liver damage induced by cyclophosphamide in mice inoculated with S180 cells
YAO Qi;NI Xiu-xiong;CHEN Wei

..............page:82-85

Effects of psychological stress on pathogenetic condition and rapeutic effect of ulcerative colitis
WANG Hao;WU Wan-chun;HAN Zhen;JIN Dao-you;WANG Meng-ya

..............page:86-90

Effect of compound salivia miltorrhiza injection on LPS-induced renal microvascular thrombosis
LIN Xi;ZUO Chang-qing;WU Tie;LU Cheng-yu

..............page:91-94

Neuroprotective effects of nGBE against glutamate excitotoxicity
SUN Jing;SUN Chang-kai;FAN Ming;DING Ai-shi;YIN Lin;WU Wei;WANG Xiao-tong

..............page:95-98

Study of toxicokinetics of bromoxynil in rabbits
LIU Xiao;LU Zhong-qiu;HU Guo-xin;XU Xue-song;LIN Hong-liang

..............page:99-103

Neuroprotection effect of Milkvetch injection in neonates with hypoxic-ischemic-encephalopathy
DOU Chang-cheng;ZHOU Ming-xiong;ZHANG Shi-fa;TAO Qing-song

..............page:104-106

Evaluation of efficacy and safety of amoxicillin and potassium clavulanate chewable tablets in treatment patients with respiratory apparatus or urinary system infection
LI Wei;ZHANG Zhen-jun

..............page:107-110

A SAS macro for analyzing measurement data in clinical trial of new drug
YU Li-li;XUE Fu-bo;LI Chan-juan;WANG Su-zhen;XU Li;WANG Ling;XIA Jie-lai

..............page:111-115

ICH E14: a new global regulatory guideline on clinical evaluation of cardiac safety for new drug development programs
Daniel Liu

..............page:116-120

quan guo lin chuang shi yan ji gou guan li zu zhi cheng li da hui hui yi ji yao

..............page:Ⅰ-Ⅱ

zhong guo lin chuang yao li xue yu zhi liao xue za zhi gao yue

..............page:插1-2